Related Experiment Video
Updated: Jun 7, 2025
11:45
Preparation of Stable Bicyclic Aziridinium Ions and Their Ring-Opening for the Synthesis of Azaheterocycles
Published on: August 22, 2018
8.4K
Design and Evaluation of Azaspirocycles as RNA binders
Claire Fleurisson1, Nessrine Graidia1, Jihed Azzouz2
1Université Paris Cité, CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, F-75006, Paris, France.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|November 13, 2024
Summary
Researchers developed new methods to synthesize unique azaspirocycles. Some of these compounds show promise as binders for HIV-1 TAR RNA, potentially aiding in drug discovery.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Drug Discovery
Background:
- Novel molecular scaffolds are crucial for advancing drug discovery.
- Azaspirocycles represent a unique class of three-dimensional structures with potential therapeutic applications.
- Targeting nucleic acids, such as RNA, is an emerging strategy in drug development.
Purpose of the Study:
- To establish efficient synthetic routes for novel azaspirocycles.
- To explore the potential of these azaspirocycles as RNA-binding agents.
- To investigate their utility in targeting specific RNA structures like HIV-1 TAR RNA.
Main Methods:
- Functionalization of bicyclic hydrazines.
- Double reductive amination.
- Intramolecular cyclizations.
- N-N bond cleavage.
- Evaluation of RNA binding affinity.
Main Results:
- Successful synthesis of novel azaspirocycles with unique 3D structures.
- Identification of compounds exhibiting strong binding to HIV-1 TAR RNA.
- Demonstration of inhibition of Tat/TAR interactions by synthesized azaspirocycles.
Conclusions:
- Efficient synthetic pathways for azaspirocycles have been developed.
- The synthesized azaspirocycles hold significant potential for medicinal chemistry and drug discovery.
- These compounds represent promising candidates for targeting RNA, specifically in the context of HIV-1.
